A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies.
Bauman J, Verschraegen C, Belinsky S, Muller C, Rutledge T, Fekrazad M, Ravindranathan M, Lee SJ, Jones D.
Bauman J, et al. Among authors: jones d.
Cancer Chemother Pharmacol. 2012 Feb;69(2):547-54. doi: 10.1007/s00280-011-1729-2. Epub 2011 Sep 8.
Cancer Chemother Pharmacol. 2012.
PMID: 21901396
Clinical Trial.